Genome-wide association studies have linked polymorphisms in the autophagy gene ATG16L1 with susceptibility to inflammatory bowel disease (IBD). However, the cell-type-specific effects of autophagy on the regulation of chronic intestinal inflammation have not been investigated. Here, we assessed the effect of myeloid-specific or intestinal epithelial cell (IEC)-specific deletion of Atg16l1 on chronic colitis triggered by the intestinal opportunistic pathogen Helicobacter hepaticus in mice. Although Atg16l1 deficiency in myeloid cells had little effect on disease, mice selectively lacking Atg16l1 in IECs (Atg16l1 VC ) developed severely exacerbated pathology, accompanied by elevated pro-inflammatory cytokine secretion and increased IEC apoptosis. Using ex vivo IEC organoids, we demonstrate that autophagy intrinsically controls TNF-induced apoptosis and in vivo blockade of TNF attenuated the exacerbated pathology in Atg16l1 VC mice. These findings suggest that the IBD susceptibility gene ATG16L1 and the process of autophagy within the epithelium control inflammation-induced apoptosis and barrier integrity to limit chronic intestinal inflammation.
In Brief
Autophagy is genetically linked with inflammatory bowel disease. Using tissue-specific Atg16l1 knockout mice, Pott et al. demonstrate that autophagy within the intestinal epithelium maintains barrier integrity and limits inflammation by protecting the cells from TNF-induced apoptosis in a model of chronic colitis.
INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with unknown etiology, with two main clinical forms: Crohn's disease (CD) and ulcerative colitis (UC). Although there are broadly conserved features of intestinal immunopathology that present in IBD patients, including dysregulated immune responses, aberrant cytokine secretion, and alterations in barrier function and intestinal microbiota (Maloy and Powrie, 2011; Neurath, 2014) , the clinical manifestations are heterogeneous (Lö nnfors et al., 2014) . The heterogeneous nature of IBD is further emphasized by genome-wide association studies (GWASs) that have identified many pathways that potentially contribute to the pathogenesis of IBD (Jostins et al., 2012; Liu et al., 2015) , and that allow further stratification of patients, besides disease manifestations and immunological profiling (de Souza et al., 2017) . Much current IBD research focuses on unraveling the mechanistic effects of genes and pathways that have been implicated by GWASs. A better understanding of how host genetics controls disease development and progression should enable treatments to be utilized in a more effective and cost-efficient manner. Current treatment options for IBD include anti-inflammatory and immune-suppressive drugs, surgery, and biologics that specifically target the dysregulated immune response (Chang and Hanauer, 2017) . In the latter category, anti-TNF treatment has high efficacy and has been increasingly employed; however, 40% of IBD patients do not respond to this therapy and many become refractory to treatment (Cohen and Sachar, 2017; Hendy et al., 2016) . As it is not fully understood how anti-TNF treatment acts and which cell types are targeted, it is difficult to predict which patients are most likely to benefit and what mechanisms prevent responsiveness.
Polymorphisms in ATG16L1 and other autophagy genes suggest an important role of autophagy in IBD pathogenesis (Hampe et al., 2007; Rioux et al., 2007) . ATG16L1 is an essential autophagy gene and the T300A polymorphism that shows the strongest link to IBD development results in destabilization of the protein, facilitating caspase 3-dependent degradation during cellular stress (Mizushima et al., 2011; Murthy et al., 2014) . Autophagy is a conserved intracellular degradation pathway that facilitates maintenance of cellular homeostasis during periods of stress or malnutrition, but it also impacts many pathways of cellular immune defense (Kabat et al., 2016b) . The ubiquitous nature of autophagy and its interactions with many other essential homeostatic cellular processes makes it difficult to unravel precisely how disease-associated polymorphisms can predispose to IBD. Nevertheless, several studies have described cell-type-specific functions of autophagy in the context of mucosal homeostasis (Adolph et al., 2013; Cadwell et al., 2008; Kabat et al., 2016a Kabat et al., , 2016b Saitoh et al., 2008) . In myeloid cells, autophagy is implicated in regulation of the proinflammatory cytokine response, particularly secretion of inflammasome-dependent cytokines, and reactive oxygen species (ROS) levels are increased in autophagy-deficient macrophages (Lassen et al., 2014; Saitoh et al., 2008; Zhang et al., 2017) . Bone marrow chimeric mice with autophagy-deficient hematopoetic cells, Atg16l1 hypomorphic mice, or mice lacking Atg16l1 in the myeloid compartment all show increased pathology in the chemically induced model of DSS colitis (Cadwell et al., 2010; Saitoh et al., 2008; Zhang et al., 2017) . Although autophagy enhances killing of Salmonella by dendritic cells (DCs) and (legend continued on next page) macrophages in vitro, how much this impacts disease development during infection is less clear (Conway et al., 2013; Thurston et al., 2012; Zhang et al., 2017) . Recent studies also revealed that autophagy in T cells is required for the maintenance of intestinal homeostasis, as Treg cells rely on autophagy for their survival and function in the gut (Kabat et al., 2016a; Wei et al., 2016) . Autophagy has also been reported to regulate many key functions of intestinal epithelial cells (IECs). Autophagy has been shown to influence granule structure of goblet and Paneth cells (secretory cells of the intestinal epithelium) under stressed conditions, such as during norovirus infection or ER stress (Adolph et al., 2013; Cadwell et al., 2010; Lassen et al., 2014; Patel et al., 2013) . Epithelial autophagy has also been implicated in barrier enforcement during Salmonella infection, as autophagy deficiency of IECs led to increased bacterial dissemination and inflammation (Benjamin et al., 2013; Conway et al., 2013; Lassen et al., 2014) . Taken together, these studies indicate that autophagy has wide-ranging functional effects on various cell types that could potentially regulate inflammatory responses. However, thus far there have been few comparative studies of the cell-type-specific effects of autophagy on the regulation of chronic intestinal inflammation. Here, we have undertaken a comprehensive analysis of the consequences of autophagy deficiency within different cellular compartments on chronic intestinal pathology. We have utilized a well-characterized mouse IBD model in which chronic intestinal inflammation is induced by infection with the gram-negative enteric bacterium Helicobacter hepaticus together with concomitant blockade of immune regulatory circuits using anti-IL10R . Our previous work has shown that this model recapitulates several features of chronic intestinal pathology found in IBD patients, that pathology is driven by similar excessive innate and adaptive immune responses, and that disease is controlled by the same key pro-inflammatory mediators Kullberg et al., 2006; Maloy et al., 2003; Schiering et al., 2014; West et al., 2017) . We find that selective autophagy deficiency in myeloid cells only marginally affects colitis development, whereas autophagy deficiency in IECs results in severely exacerbated pathology. We further show that autophagy regulates cytokine-induced apoptosis in IECs and blockade of TNF attenuates chronic colitis in IEC-specific Atg16l1-deficient mice by limiting epithelial apoptosis.
RESULTS

Autophagy Deficiency in IECs Predisposes to Chronic Colitis
To analyze the cell-type-specific role of autophagy in chronic intestinal inflammation, we crossed Atg16l1 fl/fl mice (Hwang et al., 2012) (Figure 1A ). To exclude any potential microbiota differences, the transgenic lines were bred as heterozygous for the Cre allele, allowing experimental groups to be set up using littermate controls (Atg16l1 fl/fl ) that were co-housed throughout the experiment. At 2 weeks after colitis induction, assessment of histopathology of the caecum and colon revealed slightly elevated pathology in Atg16l1
CD11c and Atg16l1 LysM mice compared to Atg16l1 fl/fl mice, but these differences were not statistically significant (Figures 1B and 1C) . Comparison with the concurrent littermate controls confirmed that there was only a minor increase in pathology and revealed no significant alterations within the lamina propria CD4 + T cell compartments in either
Atg16l1
CD11c or Atg16l1 LysM mice ( Figures S1D-S1K ).
In contrast, Atg16l1 VC mice showed significantly elevated histopathology in both the caecum and colon at 2 weeks and 4 weeks after colitis induction ( Figures 1B-1G ). Although overall disease severity varied slightly between experiments, we consistently observed significantly increased histopathology in Atg16l1 VC mice compared to their Atg16l1 fl/fl littermates. This was in accordance with increased weight loss in the Atg16l1 VC mice ( Figure 1H ) and increased numbers of CD4 + T cells in the lamina propria compared to Atg16l1 fl/fl littermates ( Figure 1I ). Figure S2 ). We also tested the role of intestinal epithelial autophagy in a model of acute intestinal infection using oral infection with Citrobacter rodentium (Collins et al., 2014) . We found that C. rodentium infection induced comparable levels of intestinal pathology in Atg16l1 VC mice and Atg16l1 fl/fl mice ( Figures S3A, S3B , S3E, and S3F), which was in accordance with similar bacterial colonization levels ( Figures  S3C and S3D ). Taken together, these data reveal that autophagy within IECs exerts a protective effect during H. hepaticus-triggered chronic colitis, whereas autophagy in myeloid cell compartments (CD11c + or LysM + cells) plays only a marginal role. Therefore, we focused our further analyses on the consequences of autophagy impairment in IECs and the impact that it has on the development of chronic colitis. (legend continued on next page)
Autophagy Does Not Regulate Chemokine Expression or ER Stress Induction in IECs
We next sought to analyze how autophagy deficiency within the epithelium influences colitis development. First, we noticed that in vivo IECs from Atg16l1 VC mice expressed elevated levels of chemokines Cxcl2 and Cxcl5 at 2 weeks and 4 weeks after colitis induction (Figures 2A and 2B ).
To analyze whether the chemokine response of the epithelium is intrinsically controlled by autophagy, we employed the ex vivo organoid system to grow primary IECs from either Atg16l1 fl/fl or Atg16l1 VC mice . Western blot analysis of LC3 lipidation confirmed autophagy deficiency in IEC organoids derived from Atg16l1 VC mice ( Figure 2D ). In the presence of complete medium containing the essential IEC growth factors (Wnt3a, R-spondin, and noggin), we found that autophagy-deficient colonic IECs proliferated and formed organoids that were morphologically indistinguishable from wild-type (WT) organoids.
To mimic the conditions present in the inflamed intestine, we isolated lamina propria leucocytes (LPLs) from colitic mice (WT mice subjected to H. hepaticus + aIL10R treatment for 2 weeks) and cultured them overnight to generate inflammatory conditioned medium (iCM) that was harvested from the culture supernatant. We then stimulated Atg16l1 fl/fl or Atg16l1 VC IEC organoids with 10% iCM to assess IEC responses to the colitic microenvironment. We found that both Atg16l1 fl/fl and Atg16l1
VC
IECs responded to stimulation with iCM, as evidenced by rapid phosphorylation and nuclear translocation of Stat3 (Figures 2C and 2D) . Western blot analysis also confirmed robust and equivalent activation of the intracellular Map kinase pathway in response to iCM stimulation in both Atg16l1 fl/fl and Atg16l1 VC IECs ( Figure 2D ). In addition, Cxcl2 and Cxcl5 expression was induced to comparable levels in Atg16l1 fl/fl and Atg16l1 VC organoids after 6 hr of stimulation with iCM ( Figures 2E and 2F ). In order to test the response of primary IECs from Atg16l1 fl/fl or Atg16l1 VC mice to bacterial stimulation, we adapted the primary IEC culture system to generate polarized monolayers (Moon et al., 2014) . Thus, IEC organoids from Atg16l1 fl/fl or Atg16l1 VC mice were seeded as monolayers and subsequently infected with H. hepaticus at the apical surface. Autophagy deficiency of the IEC monolayer derived from Atg16l1 VC mice was again verified by blotting for lipidated LC3 ( Figure 2G ). We found that both WT and autophagy-deficient IECs rapidly responded to H. hepaticus infection, with comparable phosphorylation of Erk1/2 and NFkB p65 ( Figure 2G ). Furthermore, Cxcl2 induction was also comparable between Atg16l1 fl/fl and Atg16l1 VC IECs at 6 hr post-H. hepaticus infection ( Figure 2H ).
Taken together, the ex vivo primary IEC stimulation experiments suggest that the exacerbated chemokine production observed in Atg16l1 VC mice during colitis (Figures 2A and 2B) is a consequence of the elevated inflammatory environment, rather than any intrinsic hyperactivity caused by autophagy impairment in IECs. Several recent reports have linked the ER stress pathway and autophagy in the intestinal epithelium in the context of colitis (Adolph et al., 2013; Tschurtschenthaler et al., 2017) . Therefore, we also assessed ER stress induction following iCM stimulation or H. hepaticus infection of primary IECs ex vivo. We found that Grp78 expression was not altered following iCM stimulation in either Atg16l1 fl/fl or Atg16l1 VC IEC organoids ( Figure 2I Figures 2L and 2M ). Overall, these results suggest that, under these experimental conditions, ER stress pathways in IECs do not seem to be influenced by the presence or absence of the autophagy pathway.
Autophagy Deficiency Predisposes IECs to Apoptosis
We next hypothesized that the absence of a functional autophagy pathway might predispose IECs to cell death during inflammatory conditions (Mariñ o et al., 2014) . To assess whether autophagy regulated apoptosis in IECs during chronic colitis, we assessed the number of apoptotic cells by TUNEL staining. We observed increased numbers of TUNEL-positive IECs in both caecal and colonic sections of Atg16l1 VC mice compared to Atg16l1 fl/fl littermates at 2 weeks after colitis induction (Figure 3A Figure 4B ). Furthermore, blockade of TNF and IFNg through addition of monoclonal antibodies prevented cell death and apoptosis induction in IECs ( Figures 4A and 4B) , suggesting that these cytokines were largely responsible for the apoptosis induction in response to iCM. Indeed, stimulation of IEC organoids with TNF and IFNg induced significantly higher levels of apoptosis ( Figures 4A and 4B ) and decreased metabolic activity ( Figures 4C and 4D ) in Atg16l1 VC IEC organoids compared with Atg16l1 fl/fl organoids. Western blot analysis confirmed increased apoptosis levels in the Atg16l1 VC IEC organoids after stimulation with TNF and IFNg, as they showed increased cleavage of caspases 8 and 3 (Figure 4E) , and staining for cleaved caspase 3 revealed increased numbers of apoptotic cells and disrupted cell morphology ( Figure 4F ). To confirm that TNF induced elevated IEC apoptosis in Atg16l1 VC mice, we assessed IEC apoptosis in the small intestine of mice that received an intraperitoneal (i.p.) injection of TNF (Figure 5A ). We observed that Atg16l1 VC mice lost significantly more weight than littermate controls following TNF injection ( Figure 5B ). Furthermore, TUNEL staining of small intestinal tissue sections revealed increased numbers of apoptotic IECs in Atg16l1 VC mice compared to Atg16l1 fl/fl littermates ( Figure 5C ), correlating with increased cleavage of caspase 8 in IEC lysates ( Figures 5D and 5E ). Taken together, these results demonstrate that autophagy impairment renders IECs more responsive to apoptosis induction following exposure to the pro-inflammatory cytokine milieu present in the inflamed intestine.
TNF-Induced Apoptosis Drives Exacerbated Disease in
Atg16l1
VC Mice To functionally test whether TNF was the key driver of the increased IEC apoptosis and exacerbated pathology in Atg16l1 VC mice in the complex setting of chronic colitis, we induced colitis (H. hepaticus infection + anti-IL-10R treatment) in Atg16l1 VC and Atg16l1 fl/fl littermates and concomitantly treated a group of mice with a blocking antibody against TNF (aTNF) ( Figure 6A ). We found that, in contrast to their Atg16l1 fl/fl littermates, Atg16l1 VC mice exhibited significant weight loss during the first 2 weeks after colitis induction and that this was completely prevented by treatment with aTNF ( Figure 6B ). Furthermore, aTNF treatment also reduced intestinal pathology in Atg16l1 VC mice ( Figures 6C and S4A-S4C ).
Finally, in these experiments we also assessed the influence of aTNF treatment on apoptosis levels in IECs. We found that aTNF treatment of Atg16l1 VC mice led to a marked reduction of TUNEL-positive IECs ( Figures 6D and S4D ), as well as decreased levels of cleaved caspase 8 in IEC lysates ( Figures 6E-6G ). Indeed, aTNF treatment reduced the exacerbated apoptosis induction in IECs of Atg16l1 VC mice during chronic colitis to the levels present in IECs isolated from Atg16l1 fl/fl littermates ( Figures   6D-6G ). However, following TNF blockade, some reduction of pathology was also observed in the Atg16l1 fl/fl mice and proinflammatory mediators were reduced in both Atg16l1 fl/fl and Atg16l1 VC littermates at 2 weeks of colitis ( Figures 6C, S4A -S4C, S4E, and S4F), suggesting several modes of action. In contrast, treating established colitis at day 6 post-colitis induction with aTNF resulted in reduction of pathology only in the Atg16l1 VC mice ( Figures S5A-S5C ), correlating with reduced expression of pro-inflammatory mediators ( Figures S5D and S5E) . Overall, these findings confirm that TNF-induced apoptosis of autophagy-deficient IECs is a key contributor to the exacerbated pathology, as blockade of the TNF pathway attenuates the disease.
DISCUSSION
GWASs linked polymorphisms in ATG16L1 and other autophagy genes to the development of IBD (Hampe et al., 2007; Rioux et al., 2007) , suggesting an important role of autophagy in IBD pathogenesis. However, despite extensive investigation, the mechanistic relationship between autophagy and intestinal inflammation is not fully understood. We performed comparative analyses to assess the consequences of autophagy deficiency within different cellular compartments of the intestinal mucosa. We found that autophagy deficiency in LysM + or CD11c + cells only marginally affected chronic colitis development, whereas autophagy deficiency in IECs resulted in severely exacerbated pathology.
This comparative approach, using tissue-specific Atg16l1-deficient mouse lines in the same disease model, highlights the pivotal role of autophagy in maintaining epithelial barrier function during inflammation.
Our results indicate that IECs can function quite normally without autophagy, as long as intestinal homeostasis is not perturbed. We could not detect any abnormal growth pattern, differentiation, or chemokine response of Atg16l1-deficient IECs, nor altered susceptibility during acute C. rodentium infection in Atg16l1 VC mice. C. rodentium infection induces an acute and self-limiting epithelial hyperplasia, accompanied by mild inflammation, both of which abate as the infection is cleared. In contrast, the H. hepaticus plus anti-IL-10R model results in were stimulated with TNF (100 ng/mL) and IFNg (20 ng/mL) for 18 hr and cells were stained for cleaved caspase 3 (red), the epithelial marker E-cadherin (green), and DAPI (blue). Data are representative of three independent experiments (A-F). Data are shown as mean ± SEM (A-C). Scale bar, 50 mm. Statistical significance was determined using Student's t test; *p < 0.05; **p < 0.01; ***p < 0.001. iCM, inflammatory conditioned medium; aa, anti-TNF and anti-IFNg; T, TNF, g, IFNg.
sustained activation of innate and adaptive immune circuits that drive prolonged secretion of high concentrations of pro-inflammatory cytokines. Under the severe stress conditions present during this chronic colitis, Atg16l1-deficient IECs showed increased apoptosis, which contributed to exacerbation of intestinal inflammation. The effects of autophagy deficiency in IECs have been studied in several different models and mouse strains (Adolph et al., 2013; Benjamin et al., 2013; Cadwell et al., 2008; Conway et al., 2013; Tschurtschenthaler et al., 2017) . It has been reported that autophagy deficiency in IECs resulted in enhanced bacterial translocation and inflammation following acute Salmonella challenge (Benjamin et al., 2013; Conway et al., 2013) . However, when we evaluated H. hepaticus DNA levels in mesenteric lymph nodes (MLNs) of mice in the chronic colitis model (data not shown), as well as systemic translocation of C. rodentium to liver and spleen following oral infection, we did not observe elevated levels in the Atg16l1 VC mice compared to Atg16l1 fl/fl mice. These results suggest that epithelial autophagy may be important for containing invasive intestinal pathogens, but is not essential for preventing systemic dissemination of non-invasive pathogens. Several studies reported altered granule structure in autophagy-deficient secretory IECs, such as Paneth cells and goblet cells (Adolph et al., 2013; Cadwell et al., 2008; Lassen et al., 2014; Patel et al., 2013) . This phenotype was linked to increased pathology in norovirus-infected Atg16l1 hypomorphic mice during DSS colitis (Cadwell et al., 2010) . However, whether aberrant Paneth cell morphology is a spontaneously occurring phenotype in autophagy-deficient IECs or requires an additional trigger such as viral or bacterial infection or ER stress is not clear (Adolph et al., 2013; Bel et al., 2017; Cadwell et al., 2008; Lassen et al., 2014; Patel et al., 2013) . Furthermore, in IBD patients, altered granule structure in Paneth cells was associated with the ATG16L1 T300A SNP (Cadwell et al., 2008) . How this morphologic phenotype in the small intestine might predispose to colonic inflammation is poorly understood. Altered Paneth cell morphology could lead to altered AMP secretion, which might impact microbiota composition, a plausible factor for disease susceptibility. However, it was recently described that Atg16l1 VC mice do not harbor an altered tissue-adherent microbiota in the ileum compared to Atg16l1 fl/fl mice (Tschurtschenthaler et al., 2017) . In our study, we used Atg16l1 VC and Atg16l1 fl/fl littermates to avoid any potential microbiota effects and to ensure that any differences in disease susceptibility were due to genotype. Several studies have illustrated compensatory mechanisms of ER stress and autophagy in IECs. Indeed, transgenic mice lacking both the ER stress effector Xbp1 and Atg16l1 selectively in IECs develop severely exacerbated levels of ER stress and spontaneous pathology in the ileum (Adolph et al., 2013; Tschurtschenthaler et al., 2017) . Furthermore, these investigators also reported spontaneous inflammation in the ileum of aged (>35 weeks of age) Atg16l1 VC mice, concomitant with Representative blot (E) and quantification of caspase 8 p43 (F) and p18 (G) relative to tubulin. Data are combined (B, F, and G) or representative (C-E) from three independent experiments. Each dot represents an individual mouse (F and G), or data are shown as mean ± SEM (B). Scale bars, 100 mm. Statistical significance was determined using two-way ANOVA with Bonferroni's correction for multiple comparisons. Results shown for comparison between Atg16l1 VC and Atg16l1 VC + aTNF group (B) or Mann-Whitney test; **p < 0.01; ***p < 0.001; ****p < 0.0001. H.h., enhanced ER stress levels (Tschurtschenthaler et al., 2017) . During chronic colitis induction, we observed elevated levels of Grp78 in colonic IECs, indicative of enhanced ER stress; however, we detected similar levels of Grp78 in IECs isolated from Atg16l1 fl/fl and Atg16l1 VC mice, suggesting autophagy-independent regulation of ER stress during colonic inflammation. Moreover, ex vivo primary colonic IEC organoids stimulated with inflammatory cytokines or infected with H. hepaticus exhibited ER stress responses that were independent of the Atg16l1 genotype. These findings suggest that autophagy and ER stress responses are compensatory only under certain conditions and could have different regulatory functions in the epithelium of the small intestine and colon. Our study reveals a link between autophagy and apoptosis in IECs. We found that autophagy deficiency in IECs enhanced apoptosis induction during inflammatory conditions, thereby potentially weakening the barrier integrity. Furthermore, we observed that Ag16l1-deficient IEC organoids were hyper-susceptible to TNF-induced apoptosis. Similarly, during chronic colitis we observed that high intestinal TNF levels were associated with increased numbers of apoptotic IECs in Atg16l1 VC mice, but not Atg16l1 fl/fl littermates. Of note, experimental administration of TNF also induced elevated levels of apoptosis in IECs in the small intestine of Atg16l1 VC mice, confirming an intrinsic control of IEC apoptosis by autophagy. Indeed, blocking TNF during chronic colitis resulted in a specific and marked reduction of IEC apoptosis in Atg16l1 VC mice, confirming our hypothesis that the exacerbated pathology was caused by increased apoptosis of autophagy-deficient IECs under inflammatory conditions. However, continuous blockade of TNF throughout chronic colitis resulted in reduced pro-inflammatory chemokine levels and decreased intestinal pathology in both Atg16l1 VC and Atg16l1 fl/fl mice, which indicates that TNF also has additional roles in chronic inflammation, such as immune cell activation and survival (Billmeier et al., 2016) . Furthermore, although treatment of already established colitis with aTNF does not reduce pathology in WT (Atg16l1 fl/fl ) mice (Kullberg et al., 2001; West et al., 2017) , we found that it attenuated colitis in Atg16l1 VC mice, indicating that autophagy deficiency in IECs renders the disease responsive toward aTNF treatment. Consistent with our findings, an independent study published in this issue (Burger et al., 2018) found that selective autophagy deficiency in IECs led to increased intestinal pathology following T. gondii infection that was associated with increased susceptibility to TNF-driven IEC death. In addition, they further defined a cell-intrinsic role for autophagy in Paneth cells for the maintenance of intestinal barrier function during acute infection with this parasite.
In accordance with our results, a recent study reported that autophagy deficiency also renders IECs in the small intestine hyper-susceptible to TNF-induced cell death (Matsuzawa-Ishimoto et al., 2017) . These investigators used a model of intestinal inflammation triggered by infection with murine norovirus and treatment with DSS, and primarily focused on the small intestine, where a lack of autophagy led to increased susceptibility to necroptosis and a loss of Paneth cells (Matsuzawa-Ishimoto et al., 2017) . In contrast, we observed exacerbated activation of caspase 8 and caspase 3 in Atg16l1-deficient colonic IECs and DNA fragmentation, both of which are hallmarks of apoptotic death. Therefore, although autophagy appears to generally protect IECs from TNF-induced cell death, there may be differences in the dominant death pathways triggered in distinct compartments or cell types (e.g., small intestine versus colon; Paneth cells versus absorptive enterocytes), or during different types of inflammatory challenge (e.g., norovirus + DSS versus H. hepaticus + anti-IL-10R).
These results are consistent with previous studies in which epithelial apoptosis has been linked to IBD pathology, with IECs having been described to be particularly susceptible to TNF-induced apoptosis (Takahashi et al., 2014; Zeissig et al., 2004) . For example, in a mouse model of spontaneous ileitis (SAMP1/YitFc model) a single shot of aTNF treatment ameliorated disease in the ileum correlating with reduction of epithelial apoptosis (Marini et al., 2003) . Similarly, in the Atg16l1/Xbp1 VC model of spontaneous enteritis, the pathology scores strongly correlated with the degree of epithelial apoptosis (Adolph et al., 2013) . Moreover, mice with hypomorphic expression of Atg16l1 showed increased pathology with transmural inflammation in chemically induced colitis, which was reduced to WT levels by aTNF/ aIFNg treatment (Cadwell et al., 2010) . Together with these studies, our findings emphasize the links between autophagy in IECs and regulation of apoptosis in the inflamed intestine.
Of great interest is whether IBD patients bearing polymorphisms in autophagy genes present with increased IEC apoptosis and a more severe disruption of the epithelial barrier. Although the IBD-associated ATG16L1 T300A SNP does not confer loss of function under homeostatic conditions, it results in a destabilization of the protein by enhancing caspase 3-dependent degradation (Murthy et al., 2014) . Therefore, under inflammatory conditions the T300A SNP will enhance degradation of ATG16L1 and may thereby make the IECs more susceptible to apoptosis. Interestingly, aTNF treatment of IBD patients has been linked to reduction of IEC apoptosis (Zeissig et al., 2004) ; therefore, a key future issue is to determine whether patients that harbor genetic predisposition for IEC apoptosis show better responsiveness to aTNF treatment. For example, it has been shown that SNPs in A20, an inhibitory regulator of TNF signaling, correlate with aTNF responsiveness of patients . In this context, it is striking that a recent study reported a correlation between the ATG16L1 T300A SNP and a beneficial outcome in colon cancer (Grimm et al., 2016) , which might be a result of increased apoptosis susceptibility of IECs harboring the SNP.
Overall, our study proves that impaired autophagy in epithelial cells, but not in myeloid cells, results in exacerbated chronic colonic inflammation. We showed that autophagy deficiency leads to enhanced cytokine-induced IEC apoptosis. The potential to attenuate the exacerbated pathology in Atg16l1 VC mice by aTNF treatment is of great clinical interest and may have implications for treatment of IBD patients harboring SNPs in autophagy genes.
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Detailed methods are provided in the online version of this paper and include the following: 
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Fluoview Software (Olympus, Tokyo, Japan). One representative image of the TUNEL stained sections per mouse was taken after careful screening of all sections while blinded for the genotype. We then grouped the images according to the treatment/ genotype and a different still blinded scientist in terms of genotype or treatment chose the representative image per group.
Western Blot Analysis
For immunoblot analysis cells were lysed after indicated times in RIPA buffer and 1-5 mg total protein were analyzed per lane. For detection the following primary antibodies were used: anti-LC3 antibody (L7543; Sigma-Aldrich) anti-phospho-Stat3, anti-Stat3, anti-phospho-ERK1/2, anti-phospho-Mek, anti-phospho-p65, anti-p65, anti-phospho-eIF2a, anti-eIF2a, anti-phospho-p38, anticleaved caspase 8, anti-cleaved caspase 3, (all antibodies from Cell Signaling) and anti-tubulin antibody (sc5286, Santa Cruz Biotechnology, Dallas, USA), and secondary HRP conjugated anti-rabbit or anti-mouse antibody (Cell Signaling).
Cell Death and Metabolic Assay
For cell death detection the ApoTox Glo Assay from Promega (Southampton, UK) was used. Organoids were seeded in 4 ml matrigel in a 96 well pate; following stimulation the ApoTox Glo Assay was used according to manufacturers instructions.
For the assessment of metabolic activity with AlamarBlue (Fisher Scientific) as a correlate of cell viability organoids were seeded in 4 ml matrigel in a 96 well plate. Organoids were incubated with AlamarBlue for 3 hr prior to stimulation to generate reference metabolic activity. Fluorescent intensity was measured at 540 nm/ 590 nm. Following stimulation the same procedure was repeated and values were normalized to untreated values.
RNA and qPCR
For qPCR analysis cells were lysed in RLT and RNA purified using the RNeasy kit from QIAGEN. 1-2 mg of RNA were reverse transcribed with SuperScript III reverse transcriptase (Fisher Scientific) and quantitative real-time PCR was carried out with the StepOnePlus Real time system from Applied Biosystems. RNA from sorted cell populations was purified with the RNeasy Micro kit (QIAGEN) and all RNA was transcribed. qPCR Mastermix (Eurogentec, Liege, Belgium) was used for Taqman reactions and iQ Sybr Green Supermix (Biorad, Kidlington, UK) for Sybr green reactions. Taqman probes for Cxcl2 (Mm_00436450_m1), Atg16l1 (Mm_00513084_m1) and Hprt (Mm_03024075_m1) were from Applied Biosystems and primers for Grp78 (forward: acttggg gaccacctattcct; reverse: atcgccaatcagacgctcc) for Sybr green PCR from Sigma-Aldrich. Relative expression was analyzed according to the Pfaffl method (Pfaffl, 2001 ).
Organ Explants
Pieces of 10-20 mg of colon or caecum were isolated and cultured in complete RPMI (10% FCS, 5 mM b-mercaptoethanol (Fisher Scientific), 1x Penicillin/Streptomycin (Fisher Scientific), 1x Glutamine (Fisher Scientific)) for 20 hr. Supernatants were tested for cytokine levels with the Luminex Multiplex Assay (Thermo Fisher Scientific) and normalized to input tissue weight.
Generation of Inflammatory Conditioned Medium (iCM)
LPLs were isolated from C57BL/6 mice at 2 weeks of H.h. + aIL10R colitis and 2.3x10 6 cell/ml were seeded in complete RPMI for 20 hr. Supernatants from cells of 7 mice were pooled and frozen at À80 C.
QUANTIFICATION AND STATISTICAL ANALYSIS
For weight curves p values were determined by two-way ANOVA with Bonferroni post-tests. For other experiments, p values were determined by nonparametric Mann-Whitney test, or by Kruskal-Wallis test with correction for multiple comparisons. Differences were considered statistically significant when p < 0.05 (* p < 0.05, ** p < 0.01, *** p < 0.001). Statistics were calculated using GraphPad Prism 6 software. The statistical tests applied, definition of center, dispersion and precision measures depicted, as well as the number of experimental repeats are specified in the figure legends. For in vivo experiments, sample size was determined by power analysis using power of trial software, which calculates a power value based on X 2 test statistics. Calculated required sample sizes were applied whenever possible.
